 |
SINGAPORE, Oct. 21, 2025 /PRNewswire/ — Shimadzu Asia Pacific joins the worldwide celebration of Shimadzu Corporation‘s 150th anniversary, marking a century and a half of pioneering improvements which have formed science, expertise, and healthcare worldwide.
Shimadzu’s New Analytical Factory in India, Set to Begin Operations in 2027
“As we celebrate 150 Years of Innovation, we remain committed to contributing to society through science and technology. Together with our partners, customers, and employees, we will continue developing solutions that address key challenges and create value across Asia Pacific and beyond,” stated Prem Anand, Managing Director of Shimadzu Asia Pacific.
Prem Anand, Managing Director of Shimadzu Asia Pacific and Corporate Officer of Shimadzu Corporation
150 Years of Science, Healthcare, and Innovation
Shimadzu’s lengthy historical past of innovation consists of greater than 9,000 patents, reinforcing its management in precision instrumentation. The firm has additionally developed over 50 AI-powered options throughout its analytical and medical methods, together with the world’s first robot-compatible autonomous laboratory system with LC-MS and the primary AI-driven algorithm for chromatography peak detection, Peakintelligence™.
Beyond AI, Shimadzu continues to push boundaries with the high-precision optical lattice clock, which is probably the most correct timekeeper ever developed and deviates by only one second over 30 billion years. The clock has real-world functions in earthquake detection, volcanic monitoring, and underground exploration.
Asia is coming into what many name the Asian Century, marked by financial development and technological improvement. Shimadzu Asia Pacific is supporting this progress with the opening of its first analytical manufacturing facility in Bengaluru, India, in 2027. The manufacturing facility shall be Shimadzu’s first within the Asia Pacific area to supply mass spectrometers (MS), together with numerous vary of superior analytical devices, together with liquid chromatography (LC), gasoline chromatography (GC), and ultraviolet-visible (UV) spectrophotometers.
Partnerships in Healthcare and Inclusive Growth
Shimadzu Asia Pacific continues to advance healthcare via strategic partnerships, together with the Singapore General Hospital-Shimadzu Personomics Centre, which is driving progress in customized therapy; Shimadzu-Changi General Hospital Clinomics Centre (SC3) for LCMS-based hypertension testing; and the DxD Hub Diagnomics Centre.
The firm is equally dedicated to range, fairness, and inclusion, demonstrated via a number of group initiatives in Singapore, such because the ‘Love Our Seniors’ programme, blood donation drives, and waterway clean-ups. Regionally, 150 staff have pledged in 2025 to take part in these actions, symbolically marking Shimadzu’s 150th anniversary.
Building on its historical past of technological innovation, Shimadzu will proceed to contribute to advances in well being, sustainability, and science within the years forward.
For extra details about Shimadzu Asia Pacific’s 150th anniversary actions, please go to https://www.shimadzu.com.sg/an/news/150-anniversary-celebration.html
About Shimadzu Asia Pacific
Established in 1989, Shimadzu (Asia Pacific) proudly serves because the Asia headquarters for Shimadzu Corporation, a international chief in Analytical & Measuring Instruments and Medical Systems. Backed by 150 years of innovation, the corporate delivers modern applied sciences, end-to-end options, and distinctive after-sales companies, staying true to its mission to contribute to society via science and expertise. With a devoted workforce of over 500 staff throughout 5 subsidiaries in India, Malaysia, the Philippines, and Vietnam, and a presence in additional than 18 nations, Shimadzu (Asia Pacific) is devoted to assembly numerous buyer wants.